Cefdinir is a broad-spectrum, third-generation cephalosporin antibiotic used to treat various bacterial infections, including middle ear infections, strep throat, and pneumonia.

Cefuroxime is a highly versatile, second-generation cephalosporin antibiotic. It offers a broader spectrum of antibacterial activity compared to first-generation cephalosporins, making it particularly effective against certain strains of bacteria that produce beta-lactamase. It is frequently prescribed as a reliable alternative for treating respiratory tract infections, ear infections, and urinary tract infections.

Amoxicillin/Clavulanate, widely recognised by the brand name Augmentin, is a powerful combination antibiotic. It pairs amoxicillin, a broad-spectrum penicillin, with clavulanate potassium, a beta-lactamase inhibitor. This synergistic combination is specifically designed to treat bacterial infections that have developed resistance to amoxicillin alone, making it a critical tool for more stubborn or severe infections.

Amoxicillin is a widely prescribed, moderate-spectrum, bactericidal beta-lactam antibiotic belonging to the aminopenicillin family. It is considered a crucial first-line treatment for a broad variety of common bacterial infections in both paediatric and adult populations, highly valued for its efficacy, favourable safety profile, and relatively low cost.